Page last updated: 2024-08-24

cephalosporin c and viroxime

cephalosporin c has been researched along with viroxime in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellavance, É; Décor, A; Desmeules, S; Franti, M; Garneau, M; Gauthier, A; Guo, T; Hucke, O; Laberge, MK; Leyssen, P; Lippens, J; Neyts, J; O'Meara, J; Spickler, C; Vaillancourt, FH	1

Other Studies

1 other study(ies) available for cephalosporin c and viroxime

Article	Year
Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Antiviral Agents; Benzimidazoles; Cell Line, Tumor; Cephalosporins; Common Cold; Female; HeLa Cells; Humans; Mice; Oximes; Polymorphism, Single Nucleotide; Rhinovirus; RNA Interference; RNA, Small Interfering; Sulfonamides; Thiazoles; Virus Replication	2013

Article

Year

Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.

Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Antiviral Agents; Benzimidazoles; Cell Line, Tumor; Cephalosporins; Common Cold; Female; HeLa Cells; Humans; Mice; Oximes; Polymorphism, Single Nucleotide; Rhinovirus; RNA Interference; RNA, Small Interfering; Sulfonamides; Thiazoles; Virus Replication

2013